MRNAON
MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Име MRNAON
Ранг No.
Пазарна капитализација $0.00
Целосно разводнета Пазарна капитализација $0.00
Пазарен удел %
Обем на тргување/Пазарна капитализација (24Ч) 0
Циркулирачка понуда --
Максимална понуда 0
Вкупна понуда --
Стапка на циркулација %
Датум на издавање --
Цената по која средството првпат беше издадено --
Највисоко ниво досега ,
Најниска цена ,
Јавен блокчејн MRNAON
Вовед MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Сектор
- common.mc-trade-zone-xStocks
Социјални медиуми
Анализа на текот на средства
|
Купи(MRNAON) |
Продади(MRNAON) |
Нето прилив |
| Големо |
0.000 |
0.000 |
0.000 |
| Средно |
0.000 |
0.000 |
0.000 |
| Мало |
671.861 |
2.318K |
-1645.714 |
| Вкупно |
671.861 |
2.318K |
-1645.714 |
Одрекување: податоците се обезбедени од и не треба да се сметаат за инвестициски совет.